O Yoshida

434 total citations
13 papers, 382 citations indexed

About

O Yoshida is a scholar working on Surgery, Oncology and Neurology. According to data from OpenAlex, O Yoshida has authored 13 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 4 papers in Oncology and 2 papers in Neurology. Recurrent topics in O Yoshida's work include Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Testicular diseases and treatments (2 papers) and Renal cell carcinoma treatment (2 papers). O Yoshida is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Testicular diseases and treatments (2 papers) and Renal cell carcinoma treatment (2 papers). O Yoshida collaborates with scholars based in Japan, Taiwan and United States. O Yoshida's co-authors include Yoshiyuki Kakehi, Toru Terachi, Michiaki Kohno, Hiroya Oka, Yuji Chatani, Osamu Ogawa, Rika Hoshino, Masashi Kawaichi, Akiko Fujita and Tatsunori Murata and has published in prestigious journals such as FEBS Letters, International Journal of Urology and Urologia Internationalis.

In The Last Decade

O Yoshida

12 papers receiving 370 citations

Peers

O Yoshida

MB

ONCOL

PRM

CR

PFM

Bibo Yuan China

Vilhelm A. Bohr United States

Michael Conner United States

Kati Servan Germany

Juan Lin China

G. Spatti Italy

Alina Rembiszewska Poland

Pablo García‐Sanz Spain

Xiangyun Zong China

M.J. Tilby United Kingdom

Bibo Yuan China

O Yoshida

270 ×1.1

MB

141 ×1.3

ONCOL

55 ×0.7

PRM

53 ×0.7

CR

31 ×0.6

PFM

Citations per year, relative to O Yoshida O Yoshida (= 1×) peers Bibo Yuan

Countries citing papers authored by O Yoshida

Since Specialization

Citations

This map shows the geographic impact of O Yoshida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O Yoshida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O Yoshida more than expected).

Fields of papers citing papers by O Yoshida

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O Yoshida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O Yoshida. The network helps show where O Yoshida may publish in the future.

Co-authorship network of co-authors of O Yoshida

This figure shows the co-authorship network connecting the top 25 collaborators of O Yoshida. A scholar is included among the top collaborators of O Yoshida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O Yoshida. O Yoshida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Nakamura, Ken-Ichi, Akiko Fujita, Tatsunori Murata, et al.. (1999). Rhophilin, a small GTPase Rho‐binding protein, is abundantly expressed in the mouse testis and localized in the principal piece of the sperm tail. FEBS Letters. 445(1). 9–13. 55 indexed citations

2.

Kanatani, Isao, Kenji Okumura, Hiroshi Okuno, et al.. (1998). [Synchronous multifocal development of invasive transitional cell carcinoma of the urinary tract in a patient with renal failure receiving long-term hemodialysis: a case report].. PubMed. 44(11). 821–4. 4 indexed citations

3.

Watanabe, Jun, et al.. (1996). [Asynchronous metastases solely to the bilateral adrenal glands from bladder cancer: a case report].. PubMed. 42(1). 63–6. 1 indexed citations

4.

Ohmoto, Yasukazu, et al.. (1996). An assessment of interleukin-1 alpha and interleukin-1 beta production in patients with bladder cancer.. PubMed. 16(5B). 3067–70. 1 indexed citations

5.

Oka, Hiroya, Yuji Chatani, Rika Hoshino, et al.. (1995). Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma.. PubMed. 55(18). 4182–7. 271 indexed citations

6.

Shichiri, Yasumasa, et al.. (1994). INTRA‐ARTERIAL INFUSION CHEMOTHERAPY IN COMBINATION WITH A BISCOCLAURINE ALKALOID, CEPHARANTHIN, TO TREAT BONE METASTASIS ARISING FROM RENAL CELL CARCINOMA. International Journal of Urology. 1(4). 349–351. 2 indexed citations

7.

Nishio, Yasunori, et al.. (1991). VAB-6 Chemotherapy Causes Spurious Elevation of Alpha-Fetoprotein Associated with Liver Dysfunctions. Urologia Internationalis. 46(1). 1–5. 7 indexed citations

8.

Hosokawa, S., et al.. (1990). Successful procedure for plasmapheresis and immuno adsorption treatment.. PubMed. 337. 371–3. 1 indexed citations

9.

Ueda, Kazumitsu, Yoshiaki Yamano, Noriyuki Kioka, et al.. (1989). Detection of Multidrug Resistance (MDR1) Gene RNA Expression in Human Tumors by a Sensitive Ribonuclease Protection Assay. Japanese Journal of Cancer Research. 80(11). 1127–1132. 22 indexed citations

10.

Colombo, Chiara, et al.. (1989). [Traumatic injuries of the colon: primary suture or colostomy?].. PubMed. 44(1). 25–8. 2 indexed citations

11.

Habuchi, Tomonori, et al.. (1988). Pulmonary Nodules Simulating Metastasis of Germ Cell Tumor after Aggressive Chemotherapy. Urologia Internationalis. 43(4). 248–252. 4 indexed citations

12.

Kakehi, Yoshiyuki, et al.. (1984). [Metastatic penile tumors: report of three cases].. PubMed. 30(3). 363–9. 4 indexed citations

13.

Uchino, Motoi, et al.. (1983). [Epidemiologic study of multiple sclerosis, myasthenia gravis and polymyositis in the city of Kumamoto, Japan].. PubMed. 23(10). 838–41. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact